Malaria Treatment Market Would Grow upto USD 1079.07 Million by 2030
Global Malaria Treatment Market report endows with the company profile, product specifications, production value, manufacturer’s contact information and market shares for the company. This market analysis report will definitely help in growing sales with new thinking, new skills, and innovative programs and tools. All the data, statistics, and information gathered to generate this report has been studied and analysed with the established tools and techniques such as SWOT analysis and Porter’s Five Forces analysis. The market study conducted in Global Malaria Treatment Market document takes into account heterogeneous markets in accord with the requirement of HEALTHCARE industry and scoop out the finest possible solutions and detailed information about the market trends.
Given the increased number of hospitals worldwide, the hospital pharmacy segment has taken the lead in terms of distribution channel. Furthermore, antimalarial pharmaceuticals are prescription-only medications that are usually prescribed by the specialized healthcare professionals available in hospitals, driving the expansion of this category. In contrast, the e-commerce industry is predicted to develop at the quickest rate throughout the projection period, owing to an increase in internet usage around the world.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-malaria-treatment-market&Shri
Data Bridge Market Research analyses a growth rate in the malaria treatment market in the forecast period 2023-2030. The expected CAGR of malaria treatment market is tend to be around 6.6% in the mentioned forecast period. The market value is USD 647.13 million in 2022, and it would grow upto USD 1079.07 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Growing disease burden is expected to drive the market’s growth rate
Between 2010 and 2018, significant scaling-up of malaria interventions helped to reduce malaria case incidence and fatality rates by 19% and 39%, respectively. As a result, the expanding malaria patient pool burden in both developed and developing countries is expected to drive up demand for malaria treatment products. As a result, it will contribute to the expansion of the worldwide malaria market. Malaria’s high incidence and disease burden are expected to be important driving factors in the growth of the worldwide malaria treatment industry.
Market Definition
Malaria is a kind of deadly infectious disease that is caused by the Plasmodium parasite. The varied medication categories for malaria treatment include primaquine, mefloquine, quinine, chloroquine, hydroxychloroquine, non-artemisinin based combinations (non-acts), artemisinin-based combination therapy (ACT), and others. The incidence of wide range of malaria treatment products will offer a better patient experience with reducing the risk of death.
Report Scope and Market Segmentation
| REPORT METRIC | DETAILS |
| Forecast Period | 2023 to 2030 |
| Base Year | 2022 |
| Historic Years | 2021 (Customizable to 2015- 2020) |
| Quantitative Units | Revenue in USD Million, Volumes in Units, Pricing in USD |
Key players operating in the malaria treatment market include:
- Actiza Pharmaceutical Private Limited (India)
- Amneal Pharmaceuticals LLC. (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Cipla Inc. (India)
- Lupin (India)
- Ipca Laboratories Ltd (India)
- Mylan N.V. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Zydus Group (India)
- MMV (Switzerland)
- Novartis AG (Switzerland)
- Sumaya Biotech (Germany)
- Taj Pharmaceuticals Limited (India)
- OSIVAX (France)
- Strides Pharma Science Limited (India)
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-malaria-treatment-market?Shri
Market Development
- In 2022, Tafenoquine, a new medicine that can cure a specific type of malaria, was licenced in Australia in March by Medicines for Malaria Venture (MMV), which collaborated with GlaxoSmithKline (GSK) to create the drug for children and teenagers. The medicine is used in conjunction with the standard malaria treatment, chloroquine.
- In 2020, =ADVANZ PHARMA Corp. Limited inked a contract in May to acquire Correvio Pharma Corp., a specialty pharmaceutical company. ADVANZ PHARMA now has a direct and immediate commercial presence in the Benelux nations, as well as Germany, France, Spain, and Italy, as a result of the acquisition.
Segment Analysis:
Global malaria treatment market is categorized into seven notable segments which are based on the agent, type, treatment type, drug type, route of administration, end user and distribution channel.
- On the basis of agent, the global malaria treatment market is segmented into plasmodium falciparum, P. vivax, P. ovale, P. malariae and P. knowlelsi. Plasmodium falciparum segment is dominating in the malaria treatment market and is expected to reach USD 888,377.82 thousand by 2030 due to its rapid transmission. Additionally, climate condition and humidity of Sub-Saharan Africa is enhancing the transmission of malaria by the virtue of plasmodium falciparum.
- On the basis of type, the global malaria treatment market is segmented into medication and vaccination. Medication segment is dominating in the malaria treatment market and is estimated to reach USD 814,678.23 thousand by 2030 as it is cost effective, easily accessible and is a primarily treatment for the malaria patient pool.
- On the basis of treatment type, the global malaria treatment market is segmented into suppressive treatment and radical treatment. Suppressive treatment segment is dominating in the malaria treatment market with the market share of 87.87% and is estimated to reach USD 945,788.70 thousand by 2030 because it is considered to be the primary and fundamental treatment. Moreover, enormous demand of suppressive treatment worldwide acts as another driving factor for the malaria treatment market growth.
- On the basis of drug type, the global malaria treatment market is segmented into branded and generics. Generics segment is dominating in the malaria treatment market and is estimated to reach USD 820,953.60 thousand by 2030 because it is cost-effective in comparison to the branded drugs. The growing demand of generics dugs from low and middle income countries act as another driving factor for the malaria treatment market growth.
- On the basis of route of administration, the global malaria treatment market is segmented into oral and parenteral. Oral segment is dominating in the malaria treatment market and USD 844,454.79 thousand by 2030 because it is considered the first line of therapy. Moreover, low manufacturing cost of tablets, capsules and other orally administered drugs act as another driving factor for the malaria treatment market growth.
- On the basis of end user, the global malaria treatment market is segmented into hospitals, specialty clinics, home healthcare and others. Hospitals segment is dominating in the malaria treatment market and is estimated to reach USD 981,977.50 thousand by 2030 because of the increased healthcare expenditure by hospitals on advanced medical treatment.
The hospitals segment will dominate the end user segment of the malaria treatment market
The hospitals segment will emerge as the dominating segment end user segment. This is because of the growing number of hospitals in the market especially in the developing economies. Further, growth and expansion of research development services on a global scale will further bolster the growth of this segment.
- On the basis of distribution channel, the global malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies and online pharmacies. Direct tender segment is dominating in the malaria treatment market and is estimated to reach USD 708,414.46 thousand by 2030 because most of the service providers buy the product from manufacturers and it is noticed that revenue from direct sales is higher so it is influential as well as growing in the malaria treatment market.
The direct tender segment will dominate the distribution channel segment of the malaria treatment market
The direct tender segment will emerge as the dominating segment under distribution channel. This is because of the growing number of infrastructural development activities in the market especially in the developing economies. Further, growth and expansion of the healthcare industry all around the globe will further bolster the growth of this segment.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the this research report
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-malaria-treatment-market&Shri
Some of the Most Important Questions Scrutinized in the Business Intelligence Report:
- What are the key growth parameters for this global market during the forecast period?
- Which key players are expected to hold the largest market share over the forecast period?
- Who are the leading vendors and manufacturers in this market?
- What are the key strategies adopted by leading players in the market for business development and geographical expansion?
- Which end-use industries can trigger high demand in the market over the forecast period?
- What are the key segments in this market?
- Which regional player will have anticipated leading the global market in terms of size?
- What is the impact of the novel coronavirus pandemic?
- Which obstacles must new players overcome in order to occupy a major position?
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
